QTRXQuanterix Corporation

$239M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$30M-4.8% YoY

Gross Profit

$16M54.0% margin

Operating Income

-$26M-87.1% margin

Net Income

-$21M-67.7% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-11.2%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$397M

Total Liabilities

$80M

Stockholders' Equity

$316M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$32M	-4.8%
Gross Profit	$16M	$18M	-10.5%
Operating Income	-$26M	-$15M	-74.0%
Net Income	-$21M	-$11M	-83.7%

Revenue Segments

Product

$21M36%

Consumable And Other Products

$18M32%

Service And Other Revenue

$9M15%

Research Services

$6M10%

Instruments

$3M5%

License and Service

$771,0001%

Other Services

$568,0001%

Geographic Segments

North America

$12M57%

EMEA

$5M25%

Asia Pacific

$4M18%

QTRX Q1 2025 Earnings — Quanterix Corporation Revenue & Financial Results | Market Cap Arena